Medical Device and Diagnostics Contract Market

Clinical trial is a crucial and significant step to evaluate the safety and effectiveness of a medical strategy, treatment, or device for commercial usage. These studies also help understand and determine the best medical approaches for a particular therapeutic area. Clinical trials are conducted primarily to collect data regarding the safety and efficacy of new drug and device development. Before the approval of drug molecules or medical devices by the regulatory authorities, a series of clinical studies are conducted. The increasing prevalence of various communicable and noncommunicable diseases is creating the need for the development of new drugs or medical devices, which is, in turn, propelling the demand for the medical device & diagnostics contract research organization.
Medical Device and Diagnostics Contract Market contains market size and forecasts of Medical Device and Diagnostics Contract in Global, including the following market information:
Global Medical Device and Diagnostics Contract Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Medical Device and Diagnostics Contract market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Medical Devices Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Medical Device and Diagnostics Contract include PAREXEL International Corporation, ICON PLC, WUXI APPTEC, Charles River Laboratories, Laboratory Corporation of America Holdings, North American Science Associates, Inc., Qserve Group B.V., IQVIA and Proxima Clinical Research, Inc. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Medical Device and Diagnostics Contract companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medical Device and Diagnostics Contract Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Medical Device and Diagnostics Contract Market Segment Percentages, by Type, 2021 (%)

• Medical Devices
• Diagnostics

Global Medical Device and Diagnostics Contract Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Medical Device and Diagnostics Contract Market Segment Percentages, by Application, 2021 (%)

• Clinical Data Management
• Monitoring
• Clinical Project Management
• Medical Writing
• Clinical Auditing
• Digital Health
• Clinical Strategy
• Others

Global Medical Device and Diagnostics Contract Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Medical Device and Diagnostics Contract Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Medical Device and Diagnostics Contract revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Medical Device and Diagnostics Contract revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• PAREXEL International Corporation
• ICON PLC
• WUXI APPTEC
• Charles River Laboratories
• Laboratory Corporation of America Holdings
• North American Science Associates, Inc.
• Qserve Group B.V.
• IQVIA
• Proxima Clinical Research, Inc.
• Activa CRO